Division of General Internal Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Psychooncology. 2021 Dec;30(12):2092-2098. doi: 10.1002/pon.5815. Epub 2021 Sep 19.
Cancer is the second leading cause of death for people with serious mental illness (SMI), such as schizophrenia and bipolar disorder. People with SMI receive cancer screenings at lower rates than the general population.
We sought to identify factors associated with cancer screening in a publicly insured population with SMI and stratified by race, a factor itself linked with differential rates of cancer screening.
We used Maryland Medicaid administrative claims data (2010-2018) to examine screening rates for cervical cancer (N = 40,622), breast cancer (N = 9818), colorectal cancer (N = 19,306), and prostate cancer (N = 4887) among eligible Black and white enrollees with SMI. We examined individual-level socio-demographic and clinical factors, including co-occurring substance use disorder, medical comorbidities, psychiatric diagnosis, obstetric-gynecologic and primary care utilization, as well as county-level characteristics, including metropolitan status, mean household income, and primary care workforce capacity. Generalized estimating equations with a logit link were used to examine the characteristics associated with cancer screening.
Compared with white enrollees, Black enrollees were more likely to receive screening for cervical cancer (AOR: 1.18; 95% CI: 1.15-1.22), breast cancer (AOR: 1.27; 95% CI: 1.19-1.36), and colorectal cancer (AOR: 1.07; 95% CI: 1.02-1.13), while similar rates were observed for prostate cancer screening (AOR: 1.06; 95% CI: 0.96-1.18). Primary care utilization and longer Medicaid enrollment were positively associated with cancer screening while co-occurring substance use disorder was negatively associated with cancer screening.
Improving cancer screening rates among populations with SMI should focus on facilitating continuous insurance coverage and access to primary care.
癌症是严重精神疾病(SMI)患者,如精神分裂症和双相情感障碍患者的第二大死亡原因。与一般人群相比,SMI 患者接受癌症筛查的比例较低。
我们旨在确定与 SMI 人群中与种族分层相关的癌症筛查因素,种族是与癌症筛查率差异相关的因素。
我们使用马里兰州医疗补助管理索赔数据(2010-2018 年),检查了符合条件的黑人和白人 SMI 参保者的宫颈癌(N=40622)、乳腺癌(N=9818)、结直肠癌(N=19306)和前列腺癌(N=4887)的筛查率。我们检查了个体水平的社会人口统计学和临床因素,包括同时存在的物质使用障碍、合并症、精神科诊断、妇产科和初级保健利用情况,以及县一级的特征,包括大都市地位、家庭平均收入和初级保健劳动力能力。使用带有对数链接的广义估计方程来检查与癌症筛查相关的特征。
与白人参保者相比,黑人参保者更有可能接受宫颈癌(AOR:1.18;95%CI:1.15-1.22)、乳腺癌(AOR:1.27;95%CI:1.19-1.36)和结直肠癌(AOR:1.07;95%CI:1.02-1.13)的筛查,而前列腺癌筛查的比例相似(AOR:1.06;95%CI:0.96-1.18)。初级保健的利用和更长的医疗补助入保时间与癌症筛查呈正相关,而同时存在的物质使用障碍与癌症筛查呈负相关。
提高 SMI 人群的癌症筛查率应侧重于促进持续的保险覆盖和获得初级保健。